Context Therapeutics Inc. Files 8-K
Ticker: CNTX · Form: 8-K · Filed: Apr 9, 2025 · CIK: 1842952
| Field | Detail |
|---|---|
| Company | Context Therapeutics Inc. (CNTX) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, financials
TL;DR
CTX shares unchanged as Context Therapeutics files routine 8-K with SEC.
AI Summary
Context Therapeutics Inc. filed an 8-K on April 9, 2025, reporting on various events including Regulation FD disclosures, other events, and financial statements. The company, incorporated in Delaware, is based in Philadelphia, PA, and operates in the Pharmaceutical Preparations industry.
Why It Matters
This 8-K filing provides updates on company events and financial information, which is crucial for investors to stay informed about Context Therapeutics Inc.'s operational status and regulatory compliance.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report detailing corporate events and financial statements, not indicating any immediate significant risks or changes.
Key Numbers
- 001-40654 — SEC File Number (Identifies the company's filing with the SEC.)
- 86-3738787 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Context Therapeutics Inc. (company) — Registrant
- April 9, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Philadelphia, Pennsylvania (location) — Principal executive offices
- 2834 (industry_code) — Standard Industrial Classification (SIC)
FAQ
What is the primary purpose of this 8-K filing for Context Therapeutics Inc.?
The primary purpose is to report on various events including Regulation FD disclosures, other events, and financial statements as of April 9, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on April 9, 2025.
In which state is Context Therapeutics Inc. incorporated?
Context Therapeutics Inc. is incorporated in Delaware.
What is the business address of Context Therapeutics Inc.?
The business address is 2001 Market Street, Suite 3915, Unit #15, Philadelphia, Pennsylvania 19103.
What is the Standard Industrial Classification (SIC) code for Context Therapeutics Inc.?
The SIC code for Context Therapeutics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2025 regarding Context Therapeutics Inc. (CNTX).